Immediate Impact
22 standout
Citing Papers
CAR T Cells and T-Cell Therapies for Cancer
2024 Standout
A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy
2024 Standout
Works of Tal Freund being referenced
Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy—A Single-Center Prospective Cohort Study
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Tal Freund | 124 | 209 | 86 | 13 | 292 | |
| Line Dam Heftdal | 102 | 78 | 53 | 17 | 245 | |
| Margaret Lamb | 105 | 109 | 125 | 11 | 260 | |
| Tumas Beinortas | 48 | 186 | 92 | 9 | 305 | |
| Holly Legault | 86 | 168 | 28 | 11 | 329 | |
| Daniel A. Lichtenstein | 83 | 110 | 59 | 15 | 322 | |
| Natalia Egri | 51 | 209 | 32 | 19 | 317 | |
| Stefanie Marx | 60 | 247 | 34 | 12 | 325 | |
| Johannes Kolja Hegel | 133 | 80 | 72 | 13 | 280 | |
| Ashley Otter | 47 | 198 | 58 | 19 | 261 | |
| Sara Caldrer | 45 | 159 | 44 | 19 | 335 |
All Works
Loading papers...